Software Engineer II/Sr Software Engineer (US)
Axsome Therapeutics Inc$135,000 - $190,000/year
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, AI for Drug DiscoveryIndustries
Position Overview
- Location Type: Primarily Remote (with potential for onsite visits)
- Employment Type: Full-time
- Salary: Not specified in the provided text.
Description: Genesis Therapeutics is seeking a Senior Infrastructure Engineer to build and maintain their multi-cloud compute infrastructure, supporting machine learning, computational chemistry, and drug discovery efforts. The role involves expanding monitoring, automation, and orchestration frameworks to handle growing workloads and optimize compute utilization.
Requirements
- Experience: 5+ years of experience building and maintaining cloud infrastructure at scale (e.g., AWS or GCP).
- Technical Skills:
- Proficient in Python and Bash scripting.
- Experience with Terraform and Kubernetes.
- ML Experience: Ideally, experience building and maintaining compute clusters running distributed ML training jobs with 1,000+ GPUs.
- Nice to Have: Hands-on experience with physical hardware and datacenter management.
Responsibilities
- Maintain and grow the multi-cloud compute infrastructure supporting ML model training, computational chemistry research, and drug discovery.
- Build out configuration and procedures for monitoring, resource allocation, and deployment automation.
- Develop an orchestration scheduling framework to increase execution throughput, reliability, and compute utilization across heterogeneous pipelines.
- Contribute to the expansion of autoscaling compute clusters to handle larger workloads.
Application Instructions
- The provided text does not include specific application instructions. Interested candidates should contact Genesis Therapeutics directly to inquire about the application process.
Company Information
Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. They are a leader in AI for small molecule drug discovery, utilizing their GEMS (Genesis Exploration of Molecular Space) platform.
Key Highlights:
- AI Platform: GEMS (Genesis Exploration of Molecular Space) - an advanced molecular AI platform.
- Collaborations: Partnerships with Eli Lilly and Genentech.
- Funding: Raised $200M in Series B funding in August 2023.
- Benefits: Competitive salary and equity, medical, dental, and vision insurance, and a 401(k) program.
Skills
Python
Bash scripting
Terraform
Kubernetes
Cloud infrastructure
Distributed ML training
Multi-cloud management
Monitoring
Automation
Orchestration
Resource allocation
Autoscaling
Genesis Therapeutics
AI-driven drug discovery for pharmaceuticals
About Genesis Therapeutics
Genesis Therapeutics accelerates the development of new medicines by using artificial intelligence in drug discovery. The company combines 3D spatial graph modeling and molecular simulation to identify potential drug candidates and explore new chemical spaces. Unlike its competitors, Genesis Therapeutics focuses on strategic partnerships with other biotech and pharmaceutical companies, generating revenue through upfront payments and future earnings based on drug success. The goal is to transform the drug discovery process and bring new therapies to market.
Burlingame, CaliforniaHeadquarters
2019Year Founded
$272.5MTotal Funding
SERIES_BCompany Stage
AI & Machine Learning, BiotechnologyIndustries
51-200Employees